Juvenile Arthritis Awareness Month: Teen Living with Juvenile Idiopathic Arthritis Isn’t Slowing Down
source: pixabay.com

Juvenile Arthritis Awareness Month: Teen Living with Juvenile Idiopathic Arthritis Isn’t Slowing Down

According to a story from gopresstimes.com, Lily Laurent, a 13 year old student at De Pere middle school in Wisconsin, has lived with juvenile idiopathic arthritis for nine years. While…

Continue Reading Juvenile Arthritis Awareness Month: Teen Living with Juvenile Idiopathic Arthritis Isn’t Slowing Down
Traveling with Atypical Hemolytic Uremic Syndrome: Tips for Patients
source: pixabay.com

Traveling with Atypical Hemolytic Uremic Syndrome: Tips for Patients

According to a story from ahusnews.com, traveling with atypical hemolytic uremic syndrome (aHUS) takes some extra preparation and planning ahead. This syndrome can affect multiple organ systems and especially the…

Continue Reading Traveling with Atypical Hemolytic Uremic Syndrome: Tips for Patients
This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
source: pixabay.com

This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients

Lupus nephritis causes kidney inflammation and can often lead to chronic kidney disease (CKD). An issue that medical professionals have faced is predicting the likelihood of individual patients developing CKD.…

Continue Reading This Criteria Helps Predict Chronic Kidney Disease in Lupus Nephritis Patients
Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising
source: pixabay.com

Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising

According to a story from BioSpace, the biopharmaceutical company Bioniz Therapeutics, Inc., has recently announced the release of interim results from its phase 1/2 clinical trial. This trial is investigating…

Continue Reading Interim Data from this Cutaneous T-Cell Lymphoma Trial is Looking Promising
New Drug Application for Niemann-Pick Disease Type C Treatment
source: pixabay.com

New Drug Application for Niemann-Pick Disease Type C Treatment

Orphazyme has recently submitted their New Drug Application to the FDA for their Niemann-Pick disease type C (NPC) treatment, arimoclomol. This application comes after the biopharmaceutical company was already granted…

Continue Reading New Drug Application for Niemann-Pick Disease Type C Treatment
Ankylosing Spondylitis Treatment Approved but Not Yet Available
https://pixabay.com/en/approved-pass-ok-approval-symbol-1726357/

Ankylosing Spondylitis Treatment Approved but Not Yet Available

According to Ankylosing Spondylitis News, a new treatment, Hulio, has been approved by the FDA. It is a treatment for ankylosing spondylitis and other inflammatory disorders. Although it has been…

Continue Reading Ankylosing Spondylitis Treatment Approved but Not Yet Available
Recruitment for South Korea’s Rare Disease National Bio Big Data Project Begins
source: pixabay.com

Recruitment for South Korea’s Rare Disease National Bio Big Data Project Begins

According to a story from Korea Biomedical Review, Seoul National University Hospital (SNUH) in South Korea has just announced recently that the process of recruiting patients for the National Bio…

Continue Reading Recruitment for South Korea’s Rare Disease National Bio Big Data Project Begins